ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7%
Tue, 27 Nov

ASTRAZENECA PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m1,6431,6141,6140.0%-1.8%
Other incomeRs m253434-2.0%34.4%
TurnoverRs m1,6681,6491,647-0.1%-1.2%
ExpensesRs m1,2861,5221,466-3.7%14.0%
Gross profitRs m3579314859.1%-58.6%
DepreciationRs m3736373.5%-2.0%
InterestRs m0000.0%0.0%
Profit before taxRs m3449214457.8%-58.0%
TaxRs m70285392.5%-24.2%
Profit after taxRs m274649142.8%-66.7%
Gross profit margin%21.75.79.1
Effective tax rate%20.430.136.8
Net profit margin%16.43.95.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 1.8% on a year-on-year (YoY) basis. The expenses were up by 14.0% YoY during the same period.
  • The company's operating profit declined by 58.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 9.1% in 2QFY19 as against 21.7% in 2QFY18.
  • Depreciation charges declined by 2.0% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 34.4% YoY during the quarter.
  • Net profit for the quarter declined by 66.7% YoY. Net profit margins during the quarter declined from 16.4% in 2QFY18 to 5.5% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.7% QoQ during the same period.
  • The company's operating profit increased by 59.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 9.1% in 2QFY19 as against 5.7% in 1QFY18.
  • Net profit for the quarter increased by 42.8% QoQ, while net profit margins increased from 3.9% in 1QFY18 to 5.5% in 2QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,144.2 to Rs 1,466.2, registering a Gain of Rs 322.1 or around 28.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,047.4 (down 0.9%). Over the last one year it has moved down from 14,073.9 to 14,047.4, a gain of 27 points (down 0.2%).

Overall, the S&P BSE SENSEX is up 5.2% over the year.

Current Valuations

At the current price of Rs 1,466.2, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 436.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 21.4 times.